BAXTER INTL INC's ticker is BAX and the CUSIP is 071813109. A total of 991 filers reported holding BAXTER INTL INC in Q3 2022. The put-call ratio across all filers is 1.55 and the average weighting 0.2%.
About BAXTER INTL INC
Baxter International Inc. is a global healthcare company that specializes in developing and manufacturing medical products and therapies. The company has a long history of innovation and has been at the forefront of developing life-saving treatments for patients around the world.
Baxter's product portfolio includes a wide range of medical devices, pharmaceuticals, and biotechnology products. The company's products are used in hospitals, clinics, and other healthcare settings to treat a variety of conditions, including hemophilia, immune disorders, kidney disease, and other chronic and acute medical conditions.
Baxter's commitment to innovation has helped the company maintain a strong position in the healthcare industry. The company invests heavily in research and development, and has a strong pipeline of new products in development.
Baxter's leadership team is also a key strength of the company. The CEO, José Almeida, has a strong track record of success in the healthcare industry, and has been instrumental in driving the company's growth and success.
Overall, Baxter International Inc. is a strong and innovative company that is well-positioned to continue delivering value to patients, healthcare providers, and investors alike. With a strong product portfolio, a commitment to innovation, and a talented leadership team, Baxter is a company that investors should keep an eye on in the years to come.
It's important to note that this information is for educational purposes only and has not been fact-checked. As with any investment, it's important to do your own research and consult with a financial advisor before making any investment decisions.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q4 2022 | $2,809,263 | -14.6% | 55,116 | -9.7% | 0.34% | -23.5% |
| Q3 2022 | $3,288,000 | -12.7% | 61,053 | +4.1% | 0.44% | -8.3% |
| Q2 2022 | $3,768,000 | -19.6% | 58,667 | -3.0% | 0.48% | -5.1% |
| Q1 2022 | $4,688,000 | -10.3% | 60,461 | -0.7% | 0.51% | -6.6% |
| Q4 2021 | $5,225,000 | +8.1% | 60,869 | +1.3% | 0.54% | 0.0% |
| Q3 2021 | $4,832,000 | +0.6% | 60,073 | +0.7% | 0.54% | +0.2% |
| Q2 2021 | $4,801,000 | -7.6% | 59,643 | -3.2% | 0.54% | -13.0% |
| Q1 2021 | $5,196,000 | -4.1% | 61,607 | -8.7% | 0.62% | -9.8% |
| Q4 2020 | $5,417,000 | -1.3% | 67,509 | -1.1% | 0.69% | -10.9% |
| Q3 2020 | $5,487,000 | -7.9% | 68,228 | -1.4% | 0.78% | -11.5% |
| Q2 2020 | $5,955,000 | +2.5% | 69,167 | -3.3% | 0.88% | -14.8% |
| Q1 2020 | $5,807,000 | -1.2% | 71,518 | +1.8% | 1.03% | +25.2% |
| Q4 2019 | $5,877,000 | +0.2% | 70,282 | +4.8% | 0.82% | -6.6% |
| Q3 2019 | $5,866,000 | +7.8% | 67,068 | +0.9% | 0.88% | -14.5% |
| Q2 2019 | $5,444,000 | +1.0% | 66,471 | +0.3% | 1.03% | -3.0% |
| Q1 2019 | $5,389,000 | +25.8% | 66,278 | +1.8% | 1.06% | +10.4% |
| Q4 2018 | $4,284,000 | -7.8% | 65,093 | +8.1% | 0.96% | +5.6% |
| Q3 2018 | $4,644,000 | +11.1% | 60,239 | +6.4% | 0.91% | +4.1% |
| Q2 2018 | $4,179,000 | +20.9% | 56,600 | +6.5% | 0.88% | +15.7% |
| Q1 2018 | $3,456,000 | +8.4% | 53,132 | +7.7% | 0.76% | +10.7% |
| Q4 2017 | $3,189,000 | +3.5% | 49,333 | +0.5% | 0.68% | -2.6% |
| Q3 2017 | $3,080,000 | +3.8% | 49,090 | +0.1% | 0.70% | -0.8% |
| Q2 2017 | $2,968,000 | +18.8% | 49,018 | +1.8% | 0.71% | +16.4% |
| Q1 2017 | $2,498,000 | +25.0% | 48,169 | +6.8% | 0.61% | +17.8% |
| Q4 2016 | $1,999,000 | -4.8% | 45,093 | +2.2% | 0.52% | -8.8% |
| Q3 2016 | $2,099,000 | +5.4% | 44,101 | +0.1% | 0.57% | +0.2% |
| Q2 2016 | $1,992,000 | +8.3% | 44,057 | +0.2% | 0.56% | +5.4% |
| Q1 2016 | $1,840,000 | +15.9% | 43,984 | +5.7% | 0.54% | +9.6% |
| Q4 2015 | $1,588,000 | +16.5% | 41,628 | +0.3% | 0.49% | +9.2% |
| Q3 2015 | $1,363,000 | -51.1% | 41,495 | +4.0% | 0.45% | -50.1% |
| Q2 2015 | $2,790,000 | +11.0% | 39,903 | +8.7% | 0.90% | +7.0% |
| Q1 2015 | $2,514,000 | -5.3% | 36,694 | +1.3% | 0.84% | +0.8% |
| Q4 2014 | $2,654,000 | +14.3% | 36,211 | +11.9% | 0.83% | +10.3% |
| Q3 2014 | $2,322,000 | +2.4% | 32,347 | +3.1% | 0.75% | +2.4% |
| Q2 2014 | $2,268,000 | +3.6% | 31,374 | +5.4% | 0.74% | -3.3% |
| Q1 2014 | $2,189,000 | +7.9% | 29,754 | +2.0% | 0.76% | +5.5% |
| Q4 2013 | $2,029,000 | +7.6% | 29,174 | +1.6% | 0.72% | -2.7% |
| Q3 2013 | $1,886,000 | -49.9% | 28,709 | -47.2% | 0.74% | -8.1% |
| Q2 2013 | $3,764,000 | – | 54,336 | – | 0.81% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| JONES ROAD CAPITAL MANAGEMENT, L.P. | 200,000 | $7,548,000 | 6.60% |
| BOONE CAPITAL MANAGEMENT LLC | 469,405 | $17,715,345 | 5.59% |
| Soditic Asset Management LLP | 186,920 | $7,054,361 | 5.43% |
| JONES ROAD CAPITAL MANAGEMENT, L.P. | 131,000 | $4,943,940 | 4.32% |
| Camber Capital Management LP | 3,000,000 | $113,220 | 3.73% |
| Carmignac Gestion | 4,848,773 | $182,991,718 | 3.36% |
| SHAPIRO CAPITAL MANAGEMENT LLC | 3,028,799 | $114,306,874 | 3.33% |
| Hillman Capital Management, Inc. | 219,248 | $8,274,420 | 3.19% |
| Cincinnati Specialty Underwriters Insurance CO | 201,500 | $7,604,610 | 2.90% |
| Callodine Capital Management, LP | 265,000 | $10,001,100 | 2.79% |